← Back
Data updated: Sep 20, 2026
TELIX PHARMACEUTICALS US INC
Pharma Pharmaceuticals
TELIX PHARMACEUTICALS US INC is a pharmaceutical company with 1 FDA-approved products.
2026
Since
1
Drugs
-
Trials
1
New Drugs (2yr)
Modality:
1 Small Molecules
Upcoming FDA Decisions
Full Calendar → Jan 20, 2027 — Foundayo (orforglipron)
TELIX PHARMACEUTICALS US INC's Key Drugs
TELIX PHARMACEUTICALS US INC's core commercial portfolio centers on PIXCLARA — its most strategically important drugs approved in the last 15 years.
TELIX PHARMACEUTICALS US INC's Recent FDA Approvals
TELIX PHARMACEUTICALS US INC secured 1 new FDA approval for novel drugs (NDA/BLA) in the last two years.
TELIX PHARMACEUTICALS US INC's Therapeutic Areas
Disease areas where TELIX PHARMACEUTICALS US INC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
TELIX PHARMACEUTICALS US INC Pipeline Snapshot
Active clinical trials for TELIX PHARMACEUTICALS US INC across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • PIXCLARA leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2026-09-11
- Latest
- 2026-09-11
- Applications
- 1